Bentley InnoMed is a leading global provider of covered stents for the endovascular treatment of peripheral vascular and aortic disease
Founded in 2009, Bentley InnoMed develops, manufactures, and markets innovative devices for endovascular treatments. Its focus lies on covered balloon-expandable stents used notably to treat peripheral arterial disease and abdominal aortic aneurysms.
Bentley InnoMed benefits from a global reach, with its products sold in 80+ countries across the globe. They offer the widest portfolio of covered balloon-expandable stents in the market and one of their devices, a catheter for chronic total occlusion treatment, is already FDA-approved in the U.S.
Bentley InnoMed is headquartered in Stockholm, Sweden, and totals c.400 highly qualified employees.
Headquarters
SWEDEN
Investment Year
2023
Status
